Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.00% | $173.72M | €353.99B | 39.54% | 76 Outperform | |
| AstraZeneca | 1.36% | $118.00M | £214.50B | 31.10% | 78 Outperform | |
| Roche Holding AG | 1.29% | $112.26M | CHF247.26B | 36.34% | 73 Outperform | |
| Nestlé SA | 1.23% | $106.70M | CHF202.34B | 14.84% | 71 Outperform | |
| SAP SE | 1.21% | $105.39M | €243.81B | -8.25% | 66 Neutral | |
| Novartis AG | 1.18% | $102.54M | CHF198.43B | 11.94% | 80 Outperform | |
| HSBC Holdings | 1.17% | $102.24M | £185.42B | 46.31% | 79 Outperform | |
| Shell (UK) | 1.02% | $89.19M | £160.32B | 11.40% | 74 Outperform | |
| Siemens | 0.96% | $83.19M | €177.16B | 20.74% | 74 Outperform | |
| Toyota Motor | 0.90% | $78.33M | ¥40.17T | 18.04% | 80 Outperform |